Related Experiment Video
Updated: Jan 5, 2026
Author Spotlight: Patient-Informed 3D Model for Studying Glioblastoma Invasion via Interstitial Fluid Flow
Published on: October 18, 2024
Expression of extracellular matrix markers in benign meningiomas
Asha Das1, Wan-Loo Tan, Duncan R Smith
1Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA.
Abstract:
Meningiomas have mesenchymal differentiation and studies have confirmed that meningiomas express intermediate filaments of both mesenchymal and epithelial types including vimentin and keratin. To further characterize their mesenchymal properties, particularly the role of factors requiring adhesion, extracellular matrix degradation, and migration, meningiomas were examined for a panel of extracellular matrix markers. Immunoreactivity to the matrix metalloproteinases, MMP-2 and MMP-9, and their tissue inhibitor, TIMP-1, and to an adhesion factor, galectin-3 were found in the majority of cases. The present study suggests that expression of these factors in benign meningiomas is ubiquitous and unrelated to tumor location. Therefore, these factors of the extracellular matrix may be potential targets of future therapy.
Insights
Benign meningiomas express key extracellular matrix factors like matrix metalloproteinases (MMP-2, MMP-9), TIMP-1, and galectin-3. These findings suggest potential therapeutic targets for meningioma treatment.
Area of Science:
- Neuro-oncology
- Cell Biology
- Biochemistry
Background:
- Meningiomas exhibit mesenchymal differentiation, expressing vimentin and keratin.
- Understanding mesenchymal properties is crucial for characterizing meningiomas.
Purpose of the Study:
- To investigate extracellular matrix (ECM) markers in meningiomas.
- To explore the role of adhesion, ECM degradation, and migration factors.
Main Methods:
- Immunoreactivity analysis for specific ECM markers.
- Examination of matrix metalloproteinases (MMP-2, MMP-9), TIMP-1, and galectin-3.
Main Results:
- The majority of meningioma cases showed immunoreactivity for MMP-2, MMP-9, TIMP-1, and galectin-3.
- Expression of these factors was ubiquitous and not dependent on tumor location.
Conclusions:
- Benign meningiomas universally express key ECM factors.
- These ECM factors represent potential therapeutic targets for meningioma treatment.
Related Concept Videos
02:17The Tumor Microenvironment
01:42The Extracellular Matrix
01:29The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
01:26Extracellular Matrix